Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Placebo and Escitalopram
Takeda
Panic Disorder
1 trial -
Placebo plus high-intensity statin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Plumpy'Sup
United Therapeutics Europe Ltd
Moderate Acute Malnutrition (MAM)
1 trial -
Polyethylene glycol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colonoscopy
1 trial -
Polyphenol-rich extract
Atrium Therapeutics
Healthy Elderly
1 trial -
Postoperative radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Tongue Squamous Cell Carcinoma
1 trial -
Prebiotic Fiber Supplement + loperamide hydrochloride capsule
The First People's Hospital of Lianyungang
Chemotherapy-related Diarrhea
1 trial -
Prebiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ulcerative Colitis
1 trial -
Prediction Model Arm
The First People's Hospital of Lianyungang
Lung Cancer Screening
1 trial -
Prednisolone
The First People's Hospital of Lianyungang
HIV (Human Immunodeficiency Virus)
1 trial -
Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Undifferentiated Connective Tissue Disease
1 trial -
Pregabalin capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia
1 trial -
Prepackaged Low-residue diet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colon Polyp
1 trial -
Probiotics daily
Xiyuan Hospital of China Academy of Chinese Medical Sciences
SARS-CoV-2
1 trial -
Propofol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastroscopy
1 trial -
Propranolol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Retinopathy of Prematurity
1 trial -
Propranolol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Portal Hypertension
1 trial -
Propranolol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cirrhoses
1 trial -
Propranolol Hydrochloride
United Therapeutics Europe Ltd
Post-traumatic Stress Disorder
1 trial -
Prostate biopsy guided by PSMA PET/CT
The First People's Hospital of Lianyungang
PSMA PET/CT
1 trial -
Pulsed dye laser (PDL)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Port Wine Stain
1 trial -
QFR
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
RB001
The First People's Hospital of Lianyungang
Phelan-McDermid Syndrome
1 trial -
REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
Hospital Authority, Hong Kong
Hemodynamic Instability
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources